Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?

AIMS: Current guidelines recommend initiating family screening for hypertrophic cardiomyopathy (HCM) after age 10 or 12 years unless early screening criteria are met. The aim was to evaluate if current screening guidelines miss early onset disease. METHODS AND RESULTS: Children who underwent family...

Descripción completa

Detalles Bibliográficos
Autores principales: Lafreniere-Roula, Myriam, Bolkier, Yoav, Zahavich, Laura, Mathew, Jacob, George, Kristen, Wilson, Judith, Stephenson, Elizabeth A, Benson, Leland N, Manlhiot, Cedric, Mital, Seema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885133/
https://www.ncbi.nlm.nih.gov/pubmed/31170284
http://dx.doi.org/10.1093/eurheartj/ehz396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885133/
https://www.ncbi.nlm.nih.gov/pubmed/31170284
http://dx.doi.org/10.1093/eurheartj/ehz396

Ejemplares similares